ML169 (VU0405652) is a potent, selective, and brain-penetrant positive allosteric modulator (PAM) of the M1 muscarinic acetylcholine receptor (M1 mAChR) with an EC50 of 1.38 µM; it is an MLPCN probe compound used for the study of Alzheimer’s disease.